Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. CHAHARLASHKAR Z, Saeedi Honar Y, Abdollahpour-Alitappeh M, Parvizpour S, et al
    Metastatic melanoma: An integrated analysis to identify critical regulators associated with prognosis, pathogenesis and targeted therapies.
    PLoS One. 2025;20:e0312754.
    >> Share

  2. HUGDAHL E, Aziz S, Klingen TA, Akslen LA, et al
    Prognostic value of immune biomarkers in melanoma loco-regional metastases.
    PLoS One. 2025;20:e0315284.
    >> Share

  3. SHIRALKAR J, Anthony T, McCallum GA, Durand DM, et al
    Correction: Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
    PLoS One. 2025;20:e0318831.
    >> Share

  4. LEE C, Song B, Kim E, Seo Y, et al
    68Ga-labeled fluorinated benzamide derivatives for positron emission tomography imaging of melanoma.
    PLoS One. 2025;20:e0317489.
    >> Share


  5. Expression of Concern: General sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC.
    PLoS One. 2025;20:e0323638.
    >> Share

  6. VON BUBNOFF D, Schmitt C, Goldinger SM, Schadendorf D, et al
    Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab.
    PLoS One. 2025;20:e0321937.
    >> Share

  7. PEREZ AL, Zamora M, Bahena M, Aramburo-Williams R, et al
    The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability.
    PLoS One. 2025;20:e0316983.
    >> Share

  8. THAPAR P, Rakhra M, Prashar D, Mrsic L, et al
    Skin cancer segmentation and classification by implementing a hybrid FrCN-(U-NeT) technique with machine learning.
    PLoS One. 2025;20:e0322659.
    >> Share

  9. LIANG S, Sun T, Jia XS, Cao JM, et al
    Characterization and prediction of non-melanoma skin cancer incidence in China: Joinpoint regression and age-period-cohort model.
    PLoS One. 2025;20:e0319486.
    >> Share

  10. KHONGKARAT P, Kitipaspallop W, Puthong S, Pimtong W, et al
    The in cellular and in vivo melanogenesis inhibitory activity of safflospermidines from Helianthus annuus L. bee pollen in B16F10 murine melanoma cells and zebrafish embryos.
    PLoS One. 2025;20:e0325264.
    >> Share

  11. JANKOVSKAJA S, Spegel P, Nielsen K, Bjorklund S, et al
    Non-invasive tape sampling of tryptophan and kynurenine in relation to phenylalanine and tyrosine from melanoma and adjacent non-lesional skin: A pilot study.
    PLoS One. 2025;20:e0326457.
    >> Share

  12. HERR FL, Antons MJ, Blume LV, Hirner-Eppeneder H, et al
    Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring combined anti-PD-L1/anti-CTLA-4 immunotherapy effects in a murine melanoma model with immunohistochemical validation.
    PLoS One. 2025;20:e0326675.
    >> Share

  13. EL MERTAHI A, Ezzine H, Douzi S, Douzi K, et al
    AI-driven skin cancer detection from smartphone images: A hybrid model using ViT, adaptive thresholding, black-hat transformation, and XGBoost.
    PLoS One. 2025;20:e0328402.
    >> Share

  14. KOSHAREK AT, Zuleger CL, Glass WS, Eickhoff J, et al
    In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma.
    PLoS One. 2025;20:e0330200.
    >> Share

  15. TOLD R, Reumueller A, Kreminger J, Sacu S, et al
    Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis.
    PLoS One. 2025;20:e0328360.
    >> Share

  16. WANG H, Zhang Y, Zhang Y, Zhao X, et al
    SpaVGN: A hybrid deep learning framework for high-resolution spatial transcriptomics data reconstruction and spatial domain identification.
    PLoS One. 2025;20:e0329122.
    >> Share

    January 2024
  17. PEISEN F, Gerken A, Dahm I, Nikolaou K, et al
    Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy.
    PLoS One. 2024;19:e0296253.
    >> Share

  18. WIES C, Schneider L, Haggenmuller S, Bucher TC, et al
    Evaluating deep learning-based melanoma classification using immunohistochemistry and routine histology: A three center study.
    PLoS One. 2024;19:e0297146.
    >> Share

  19. LIU Y, Wang S, Wei S, Qiu X, et al
    The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis.
    PLoS One. 2024;19:e0290986.
    >> Share

  20. SHIRALKAR J, Anthony T, McCallum GA, Durand DM, et al
    Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
    PLoS One. 2024;19:e0297281.
    >> Share

  21. VON MONTFORT C, Aplak E, Ebbert L, Wenzel CK, et al
    The role of GAPDH in the selective toxicity of CNP in melanoma cells.
    PLoS One. 2024;19:e0300718.
    >> Share

  22. NAEEM A, Anees T
    DVFNet: A deep feature fusion-based model for the multiclassification of skin cancer utilizing dermoscopy images.
    PLoS One. 2024;19:e0297667.
    >> Share

  23. JEONG H, Cho YR, Gim J, Cha SK, et al
    GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
    PLoS One. 2024;19:e0291223.
    >> Share


  24. Retraction: Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
    PLoS One. 2024;19:e0300807.
    >> Share

  25. ALSHAHRANI M, Al-Jabbar M, Senan EM, Ahmed IA, et al
    Analysis of dermoscopy images of multi-class for early detection of skin lesions by hybrid systems based on integrating features of CNN models.
    PLoS One. 2024;19:e0298305.
    >> Share

  26. ZHANG L, Zhang L, Zhang C, Shi S, et al
    circTADA2A inhibited SLC38A1 expression and suppresses melanoma progression through the prevention of CNBP trans-activation.
    PLoS One. 2024;19:e0301356.
    >> Share

  27. BUJA A, Rugge M, Cozzolino C, Dossi F, et al
    Could the mitotic count improve personalized prognosis in melanoma patients?
    PLoS One. 2024;19:e0302309.
    >> Share

  28. COURTENAY LA, Barbero-Garcia I, Martinez-Lastras S, Del Pozo S, et al
    Near-infrared hyperspectral imaging and robust statistics for in vivo non-melanoma skin cancer and actinic keratosis characterisation.
    PLoS One. 2024;19:e0300400.
    >> Share

  29. DHEIN ES, Heikkila U, Oevermann A, Blatter S, et al
    Incidence rates of the most common canine tumors based on data from the Swiss Canine Cancer Registry (2008 to 2020).
    PLoS One. 2024;19:e0302231.
    >> Share


  30. Retraction: Combination effect of cold atmospheric plasma with green synthesized zero-valent iron nanoparticles in the treatment of melanoma cancer model.
    PLoS One. 2024;19:e0304502.
    >> Share

  31. ZHANG W, Patterson NH, Verbeeck N, Moore JL, et al
    Multimodal MALDI imaging mass spectrometry for improved diagnosis of melanoma.
    PLoS One. 2024;19:e0304709.
    >> Share

  32. ABUH SO, Barbora A, Minnes R
    Metastasis diagnosis using attenuated total reflection-Fourier transform infra-red (ATR-FTIR) spectroscopy.
    PLoS One. 2024;19:e0304071.
    >> Share

  33. GUO X, Guo Z, Bai P, Guo C, et al
    GPR168 functions as a tumor suppressor in mouse melanoma by restraining Akt signaling pathway.
    PLoS One. 2024;19:e0302061.
    >> Share

  34. FRIEDMAN AA, Amzallag A, Pruteanu-Malinici I, Baniya S, et al
    Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
    PLoS One. 2024;19:e0306658.
    >> Share

  35. XU C, Yu X, Ding Z, Fang C, et al
    Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma.
    PLoS One. 2024;19:e0305468.
    >> Share

  36. WU X, Marmarelis ME, Stephen Hodi F
    Correction: Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma.
    PLoS One. 2024;19:e0309769.
    >> Share

  37. WADT KAW, Harbst K, Sjol MMB, Rosengren F, et al
    Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants.
    PLoS One. 2024;19:e0306386.
    >> Share


  38. Expression of Concern: Fisetin Inhibits Human Melanoma Cell Invasion through Promotion of Mesenchymal to Epithelial Transition and by Targeting MAPK and NFkappaB Signaling Pathways.
    PLoS One. 2024;19:e0313108.
    >> Share

  39. CHUNG HJ, Seo N, Han K, Bae H, et al
    Gadoxetic acid-enhanced MRI for the detection of liver metastases from melanoma.
    PLoS One. 2024;19:e0313212.
    >> Share

  40. COHEN G, Rapoport B, Chan SW, Ruff P, et al
    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.
    PLoS One. 2024;19:e0309778.
    >> Share


  41. Retraction: Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1alpha in Melanoma Cells.
    PLoS One. 2024;19:e0315282.
    >> Share

    January 2023
  42. ALI A, Madni A, Shah H, Jamshaid T, et al
    Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
    PLoS One. 2023;18:e0281004.
    >> Share

  43. SHAO H, Teramae D, Wells A
    Axl contributes to efficient migration and invasion of melanoma cells.
    PLoS One. 2023;18:e0283749.
    >> Share


  44. Retraction: Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.
    PLoS One. 2023;18:e0282986.
    >> Share

  45. ORLOW I, Sadeghi KD, Edmiston SN, Kenney JM, et al
    InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
    PLoS One. 2023;18:e0269324.
    >> Share

  46. TAJERIAN A, Kazemian M, Tajerian M, Akhavan Malayeri A, et al
    Design and validation of a new machine-learning-based diagnostic tool for the differentiation of dermatoscopic skin cancer images.
    PLoS One. 2023;18:e0284437.
    >> Share

  47. PANG JM, Chien PC, Kao MC, Chiu PY, et al
    MicroRNA-708 emerges as a potential candidate to target undruggable NRAS.
    PLoS One. 2023;18:e0284744.
    >> Share

  48. TABATABAI MA, Bahri N, Matthews-Juarez P, Alcendor D, et al
    The role of histological subtypes in the survival of patients diagnosed with cutaneous or mucosal melanoma in the United States of America.
    PLoS One. 2023;18:e0286538.
    >> Share

  49. ZHU H, Zhang P, Shi J, Kou D, et al
    Exosome-delivered circRPS5 inhibits the progression of melanoma via regulating the miR-151a/NPTX1 axis.
    PLoS One. 2023;18:e0287347.
    >> Share

  50. DIVINCENZO MJ, Angell CD, Suarez-Kelly LP, Ren C, et al
    Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    PLoS One. 2023;18:e0285804.
    >> Share

  51. MA W, Wu Z, Maghsoudloo M, Ijaz I, et al
    Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
    PLoS One. 2023;18:e0285806.
    >> Share

  52. KUHN CK, Meister J, Kreft S, Stiller M, et al
    TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities.
    PLoS One. 2023;18:e0281487.
    >> Share

  53. CLEVENGER LM, Wrenn JD, Bena J, Sodhi G, et al
    Clustering of uveal melanoma: County wide analysis within Ohio.
    PLoS One. 2023;18:e0290284.
    >> Share

  54. HOCK BD, Goddard L, MacPherson SA, Strother M, et al
    Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab.
    PLoS One. 2023;18:e0290793.
    >> Share

  55. MAEKAWA N, Konnai S, Hosoya K, Kim S, et al
    Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
    PLoS One. 2023;18:e0291727.
    >> Share

  56. CHAN LH, Wang P, Abuhammad S, Lim LRJ, et al
    PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma.
    PLoS One. 2023;18:e0292278.
    >> Share


  57. Retraction: Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.
    PLoS One. 2023;18:e0294549.
    >> Share

  58. BONERT M, Berzins A, Begum H, Schittenhelm J, et al
    Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history.
    PLoS One. 2023;18:e0294154.
    >> Share

  59. SOARES PRO, Passos DCS, da Silva FM, da Silva-Giardini APB, et al
    In vitro antiproliferative and apoptotic effects of thiosemicarbazones based on (-)-camphene and R-(+)-limonene in human melanoma cells.
    PLoS One. 2023;18:e0295012.
    >> Share

  60. DUNLOP KLA, Keogh LA, Smith AL, Aranda S, et al
    Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants.
    PLoS One. 2023;18:e0287591.
    >> Share

  61. KHAN S, Khan A
    SkinViT: A transformer based method for Melanoma and Nonmelanoma classification.
    PLoS One. 2023;18:e0295151.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016